CBI Fundamental Analysis - COLIBRI RESOURCES CORP

Name: COLIBRI RESOURCES CORP (CBI) Stock
Brand: COLIBRI RESOURCES CORP
Rating: 6 (3 reviews)

Fundamental Rating

CBI gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of CBI have multiple concerns. CBI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

CBI had negative earnings in the past year.

CBI had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: CBI reported negative net income in multiple years.

In the past 5 years CBI always reported negative operating cash flow.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-20.34%
ROE	-39.99%
ROIC	N/A

ROA(3y)-17.1%

ROA(5y)-9.34%

ROE(3y)-28.4%

ROE(5y)-15.33%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CBI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, CBI has more shares outstanding

CBI has more shares outstanding than it did 5 years ago.

CBI has a worse debt/assets ratio than last year.

2.2 Solvency

CBI has an Altman-Z score of -3.72. This is a bad value and indicates that CBI is not financially healthy and even has some risk of bankruptcy.

CBI has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.

		Industry Rank	Sector Rank
Debt/Equity	0.25
Debt/FCF	N/A
Altman-Z	-3.72

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.06 indicates that CBI may have some problems paying its short term obligations.

CBI has a Quick Ratio of 0.06. This is a bad value and indicates that CBI is not financially healthy enough and could expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.06
Quick Ratio	0.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.89%.

EPS 1Y (TTM)-19.89%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-22%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CBI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

COLIBRI RESOURCES CORP

TSX-V:CBI (1/7/2026, 7:00:00 PM)

0.295

0 (0%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)12-01 2025-12-01

Earnings (Next)04-27 2026-04-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners8.3%

Ins Owner ChangeN/A

Market Cap9.74M

Revenue(TTM)N/A

Net Income(TTM)-950.90K

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	4.1
P/tB	4.1
EV/EBITDA	N/A

EPS(TTM)-0.04

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)-0.01

OCFYN/A

SpS0

BVpS0.07

TBVpS0.07

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-20.34%
ROE	-39.99%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-17.1%

ROA(5y)-9.34%

ROE(3y)-28.4%

ROE(5y)-15.33%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.25
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	104.79%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.06
Quick Ratio	0.06
Altman-Z	-3.72

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)890.59%

Cap/Depr(5y)1082.39%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-19.89%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-22%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y9.77%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y77.54%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y41.05%

OCF growth 3YN/A

OCF growth 5YN/A

COLIBRI RESOURCES CORP / CBI.CA FAQ

What is the fundamental rating for CBI stock?

ChartMill assigns a fundamental rating of 0 / 10 to CBI.CA.

Can you provide the valuation status for COLIBRI RESOURCES CORP?

ChartMill assigns a valuation rating of 0 / 10 to COLIBRI RESOURCES CORP (CBI.CA). This can be considered as Overvalued.

How profitable is COLIBRI RESOURCES CORP (CBI.CA) stock?

COLIBRI RESOURCES CORP (CBI.CA) has a profitability rating of 0 / 10.

COLIBRI RESOURCES CORP (CBI.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

COLIBRI RESOURCES CORP / CBI.CA FAQ

What is the fundamental rating for CBI stock?

Can you provide the valuation status for COLIBRI RESOURCES CORP?

How profitable is COLIBRI RESOURCES CORP (CBI.CA) stock?